These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3205387)

  • 1. Dose-catalepsy response to haloperidol in rat: effects of strain and sex.
    Campbell A; Baldessarini RJ; Cremens MC
    Neuropharmacology; 1988 Nov; 27(11):1197-9. PubMed ID: 3205387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in catalepsy response in inbred rats during chronic haloperidol treatment is not predictive of the intensity of behavioral hypersensitivity which subsequently develops.
    Kinon BJ; Kane JM
    Psychopharmacology (Berl); 1989; 98(4):465-71. PubMed ID: 2505286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes.
    Erosa-Rivero HB; Bata-García JL; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL
    Neuropharmacology; 2014 Jun; 81():176-87. PubMed ID: 24534110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline reverses haloperidol-induced catalepsy in the rat. Possible relevance to the pharmacological treatment of psychosis.
    Casas M; Ferre S; Guix T; Jane F
    Biol Psychiatry; 1988 Oct; 24(6):642-8. PubMed ID: 3167148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and haloperidol-induced versus handling-related catalepsy in male rats.
    De Ryck M; Hruska RE; Silbergeld EK
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1027-35. PubMed ID: 7178196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants.
    Barnes DE; Robinson B; Csernansky JG; Bellows EP
    Pharmacol Biochem Behav; 1990 Aug; 36(4):883-7. PubMed ID: 2217518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol.
    Umathe SN; Wanjari MM; Manna SS; Jain NS
    Neuropeptides; 2009 Jun; 43(3):251-7. PubMed ID: 19403167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy.
    Johnson SK; Fisher H; Wagner GC
    Neuropharmacology; 1993 Mar; 32(3):273-8. PubMed ID: 8474623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High dosage haloperidol reduces cataleptic response with increased noradrenaline metabolism in the rat brain areas].
    Takashima M; Toru M
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):149-58. PubMed ID: 6687201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalepsy induced by SCH 23390 in rats.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic dose-response effect of baclofen on haloperidol catalepsy in the rat.
    Richardson JS; Richardson AK
    Pharmacol Biochem Behav; 1982 Oct; 17(4):855-6. PubMed ID: 6891066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat.
    Prescott WR; Gold LH; Martin BR
    Psychopharmacology (Berl); 1992; 107(1):117-24. PubMed ID: 1317040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian changes in the destruction and effects of haloperidol in the rat.
    Campbell A; Herschel M; Sommer B; Madsen JR; Cohen BM; Baldessarini RJ
    Neuropharmacology; 1982 Jul; 21(7):663-9. PubMed ID: 6889690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine potentiates the behavioral effects of haloperidol.
    Emerich DF; Norman AB; Sanberg PR
    Psychopharmacol Bull; 1991; 27(3):385-90. PubMed ID: 1775613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance of haloperidol catalepsy.
    Ezrin-Waters C; Seeman P
    Eur J Pharmacol; 1977 Feb; 41(3):321-7. PubMed ID: 556989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of haloperidol-induced catalepsy by ascorbic acid in rats and nonhuman primates.
    Dorris RL; Dill RE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):781-3. PubMed ID: 3703914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine potentiates haloperidol-induced catalepsy and locomotor hypoactivity.
    Emerich DF; Zanol MD; Norman AB; McConville BJ; Sanberg PR
    Pharmacol Biochem Behav; 1991 Apr; 38(4):875-80. PubMed ID: 1871200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine may not produce true catalepsy.
    Feigenbaum JJ; Yanai J; Moon BH; Klawans HL
    Int J Neurosci; 1983; 18(3-4):199-203. PubMed ID: 6683262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of serotonergic agents on haloperidol-induced catalepsy.
    Hicks PB
    Life Sci; 1990; 47(18):1609-15. PubMed ID: 2250574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.